Figure 3From: Potential antitumor effects of nitrogen-containing bisphosphonate in hormone receptor negative breast cancer patients with bone metastases Patients with HR negative metastatic bone disease. (A) TTP_BD (P = 0.163), (B) OS (P = 0.040).Back to article page